Floatz logo

bp102

Advanced or Metastatic Non-squamous Non-small Cell Lung Cancer

Suzhou Suncadia Biopharmaceuticals Co., Ltd.Phase 3Active
BB
64/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
49/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Advanced or Metastatic Non-squamous Non-small Cell Lung Cancer cohort.

Asset / SponsorPhaseRating

Same molecule, other indications

bp102 is also rated in:

cancerDormant
B
Indicative ·
60 / 100
View asset →
Malignant Solid TumorsDormant
CCC
Indicative ·
53 / 100
View asset →
triple-negative breast carcinomaDormant
CCC
Indicative ·
53 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →